Nanologica AB (publ) (STO:NICA)
0.3040
-0.0060 (-1.94%)
Sep 22, 2026, 5:29 PM CET
Nanologica AB Employees
Nanologica AB had 72 employees as of June 30, 2026. The number of employees increased by 54 or 300.00% compared to the same quarter last year.
Employees
72
Change
54
Growth
300.00%
Revenue / Employee
1.80M SEK
Profits / Employee
260.97K SEK
Market Cap
99.95M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 72 | 54 | 300.00% |
| Mar 31, 2026 | 72 | 56 | 350.00% |
| Dec 31, 2025 | 19 | 3 | 18.75% |
| Sep 30, 2025 | 19 | 3 | 18.75% |
| Jun 30, 2025 | 18 | 2 | 12.50% |
| Mar 31, 2025 | 16 | 0 | - |
| Dec 31, 2024 | 16 | 0 | - |
| Sep 30, 2024 | 16 | 2 | 14.29% |
| Jun 30, 2024 | 16 | -3 | -15.79% |
| Mar 31, 2024 | 16 | -4 | -20.00% |
| Dec 31, 2023 | 16 | -4 | -20.00% |
| Sep 30, 2023 | 14 | -6 | -30.00% |
| Jun 30, 2023 | 19 | 2 | 11.76% |
| Mar 31, 2023 | 20 | 2 | 11.11% |
| Dec 31, 2022 | 20 | 3 | 17.65% |
| Sep 30, 2022 | 20 | 0 | - |
| Jun 30, 2022 | 17 | -3 | -15.00% |
| Mar 31, 2022 | 18 | -2 | -10.00% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Biovica International AB | 24 |
| NextCell Pharma AB | 24 |
| Xintela AB | 11 |
| Ascelia Pharma AB | 10 |
| Alzinova AB | 7 |
| Spago Nanomedical AB | 6 |
| Active Biotech AB | 5 |
| Simris Group AB (PUBL) | 5 |
Nanologica AB News
- 23 days ago - Nanologica AB Quarterly report: Q2 2026 - Filings
- 4 months ago - Nanologica AB Quarterly report: Q1 2026 - Filings
- 6 months ago - Nanologica AB Quarterly report: Q4 2025 - Filings
- 6 months ago - Nanologica AB Annual report: Q4 2025 - Filings
- 11 months ago - Nanologica AB Quarterly report: Q3 2025 - Filings